InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-63.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Discover the complete record of transactions filed by Stanleick Andrew Roy, Chief Executive Officer. Director active across 1 company, notably Beauty Health Co. In total, 4 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €92k. History available since 17 August 2023. The latest transaction was filed on 17 August 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Stanleick Andrew Roy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
16,485 shares@ US$6.0549100.0% of flowClass A Common StockSEC:0001628280-23-029852:0
Canonical exit: 15 Nov 2023 (T+90)
294,579 sharesClass A Common StockSEC:0001628280-23-011061:0
58,536 sharesClass A Common StockSEC:0001818093-23-000011:0
333,333 sharesClass A Common StockSEC:0001818093-22-000035:0
4 of 4 declarations
About Stanleick Andrew Roy
Andrew Roy Stanleick is the Chief Executive Officer at Beauty Health Co. He is responsible for the strategic and operational leadership of the company. His leadership is crucial for developing innovative products and meeting the needs of the health and beauty market.
